India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
Story summaryThe first wave of generic versions of Novo Nordisk's GLP-1 weight-loss drugs launched in India over the weekend, with at least five domestic drugmakers undercutting the original price by up to 80%. It comes as the Danish drugmaker's patent expired on Friday, with the company fighting to maintain its lead in the lucr…
Read at CNBCOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.